Plegridy approved for relapsing remitting MS in England
NICE has published its final decision recommending that Plegridy can be prescribed by the NHS for relapsing remitting MS.
In May 2018, NICE carried out a review of several of the MS drugs and decided that Avonex, Extavia, Rebif, Copaxone and Brabio should continue to be available on the NHS in England. At the time, NICE was unable to make a recommendation on Plegridy and has now completed a separate appraisal.
The MS Trust contributed throughout the process.
We are pleased that NICE has approved Plegridy for people with relapsing remitting MS. We were able to make a strong case to NICE thanks to those of you who told us about your experiences of taking this treatment and the importance of having a greater choice of disease modifying drugs.
- David Martin, Chief Executive Officer, MS Trust
Plegridy (peginterferon beta 1a) is a disease modifying drug for relapsing remitting MS which you inject once a fortnight. Plegridy is already approved for use in Scotland and Wales.
Find out more about Plegridy.
Find out more
- NICE decision
- Plegridy
- Disease modifying drugs
- MS Decisions - find out about disease modifying drugs for relapsing MS
Ozanimod (Zeposia) approved for relapsing remitting MS in Scotland
8 Feb 2021 - 00:00
The MS Trust is delighted that ozanimod (Zeposia) has been approved in Scotland for people with active relapsing remitting multiple sclerosis.
Exercise is good for your brain
3 Feb 2021 - 00:00
There is more to exercise than physical fitness. This review looks at recent research which shows how exercise has a direct beneficial effect on brain repair processes.
Covid-19 vaccines and MS: Part two
29 Jan 2021 - 00:00
Following our last interview on the subject of the Covid-19 vaccine and people with MS, we received a lot of follow up questions. To answer some of these, we spoke once again to Professor Alasdair Coles, Consultant Neurologist at Addenbrooke’s hospital.
My search for MS support while studying for a PhD
4 Mar 2021 - 00:00
Laura is studying a PhD in Cancer Genomics and was diagnosed with MS in September 2020 following multiple hospital admissions. Here, Laura talks about how this affected her mental health and what more could be done to support other students going through the same thing.
MS, my mental health and a university degree
4 Mar 2021 - 00:00
Scarlet talks about how she learnt to manage her MS and mental health alongside the stresses of completing a university degree.
Receiving an MS diagnosis during my gender transition
22 Feb 2021 - 00:00
Chris shares his experience of being diagnosed with MS at the same time as starting hormone treatment and a surgical gender transition.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
